You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Procter & Gamble Co,The in Consumer Health

Sep 2012

Price: US$525

About this Report

About this Report


Euromonitor International's report on Procter & Gamble Co, The delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.

Company and market share data provide a detailed look at the financial position of Procter & Gamble Co, The, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Procter & Gamble Co, The This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Procter & Gamble Co, The provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

Strategic Evaluation

Procter & Gamble attempts to join in on generic push

Developing and developed markets divide

Volumes fall in personal health care in Q4 2012

SWOT: Procter & Gamble Co, The

Procter & Gamble: focuses on core businesses

Competitive Positioning

Procter & Gamble focuses on a few core brands

Procter & Gamble sales growth driven by emerging markets

Market Assessment

Growth to be led by emerging markets

Procter & Gamble extensive presence in consumer health

Category and Geographic Opportunities

Cough, cold and allergy dominates P&G sales

Emerging markets offset North American contraction

China to lead growth in CCA but a difficult market to break into

Vicks brand gives P&G wide CCA presence

Probiotics and laxatives offer opportunity in US market

Digestive remedies to contract over the forecast period

Expand into children’s cough, cold and allergy remedies in Brazil

Indian market offers chance to offset mature market decline

Build a global presence for Align

Eastern Europe to open up for P&G with Teva

Brand Strategy

Johnson & Johnson’s loss is Vicks’ gain

Prilosec continues to struggle

Metamucil benefits from natural trend in laxatives

Operations

P&G operates global distribution and manufacturing

P&G emerging market manufacturing sites by country 2011

Recommendations

Expansion beyond US market

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!